The new lab will leverage PacBio’s HiFi sequencing technology to broaden access to highly accurate long-read sequencing and multi-omics solutions in Southeast Asia SINGAPORE — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, in collaboration with the Agency for Science, Technology, and Research (A*STAR), and Macrogen, today announced the opening of a […]

The nanopore sequencing pilot programme aims to expand our understanding of the causes of rare genetic disease and cancer and evaluate potential for future routine clinical use. Oxford Nanopore Technologies is entering into a strategic collaboration with UMC Utrecht, one of the leading academic medical centres in the Netherlands, that will aim to explore the […]

Illumina Is the genomic sequencing partner for Otsuka Pharmaceutical Japan’s blood cancer assay HemeSight®, the first-in-Japan comprehensive genomic profiling assay for blood cancer, recently received its first regulatory approval. ‘We are very pleased with the approval of HemeSight in Japan. As Otsuka Pharmaceutical’s technology partner for genomic sequencing, we are proud to support Otsuka and […]

This collaboration will integrate Atinary’s AI-driven and automated process optimization technology with Snapdragon’s state-of-the-art laboratories and process development capabilities to tackle complex challenges in drug development. MENLO PARK, California and LAUSANNE, Switzerland —  Atinary Technologies, whose leading no-code AI platform, SDLabsTM, and Self-Driving LabsTM technology are transforming research and development (R&D) of new molecules and chemicals, […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced that one of its spatial biology brands, Lunaphore, is partnering with Discovery Life Sciences (Discovery) to add Lunaphore COMET™, a best-in-class spatial biology platform, to Discovery’s global suite of biospecimen products and specialty lab services supporting customers with clinical research. The strategic partnership leverages Lunaphore’s COMET technology, the only fully-automated, high-throughput, hyperplex […]

New partnership will increase access to BioSkryb’s industry-leading single-cell multiomics technology DURHAM, N.C. – BioSkryb Genomics,a company ushering in the next generation of single-cell technology, today announced a partnership with the Human Cell Atlas (HCA), a global consortium that is mapping every cell type in the human body, creating a 3-dimensional Atlas of human cells to […]

ATCC will provide a broad range of in vivo and in vitro models, as well as specialized reagents, for use in infectious disease treatment and research. Manassas, VA, United States — ATCC, the world’s premier biological materials management and standards organization, today announced that it has been awarded a seven-year Indefinite Delivery/Indefinite Quantity (IDIQ) contract […]

Oxford Nanopore Technologies and King Abdullah University of Science and Technology (KAUST) have signed a Memorandum of Understanding (MoU) to collaborate on the research and development of advanced multi-omics technologies. This strategic collaboration will leverage Oxford Nanopore’s innovative nanopore sequencing technology and KAUST’s strong research base to accelerate scientific discoveries that address critical global health […]

Innovation Delivers High-Fidelity, Scalable, Non-Toxic On-Premises Biofoundry Capabilities SAN DIEGO — A new partnership between Telesis Bio and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, will create efficient and scalable biofoundries, delivering solutions for sustainable and rapid on-premise synthesis of DNA. This innovative approach enabled by Telesis Bio’s Gibson SOLA […]

Setting new benchmarks in cancer treatment research, Cytiva’s Via Extractor tissue disaggregator is being used to create dissociated tumor cell suspensions with high viability and yield. The collaboration focuses on improving patient outcomes through the ​personalized ​evaluation of ​treatment efficacy on ​patient-derived tumors. Cytiva, a global leader in life sciences, and Pear Bio, a pioneer […]